Four-Week Studies of Oral Hypoxia-Inducible Factor–Prolyl Hydroxylase Inhibitor GSK1278863 for Treatment of Anemia

Hypoxia-inducible factor prolyl hydroxylase inhibitors stabilize levels of hypoxia-inducible factor that upregulate transcription of multiple genes associated with the response to hypoxia, including production of erythropoietin. We conducted two phase 2a studies to explore the relationship between t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Am Soc Nephrol
Autores principales: Holdstock, Louis, Meadowcroft, Amy M., Maier, Rayma, Johnson, Brendan M., Jones, Delyth, Rastogi, Anjay, Zeig, Steven, Lepore, John J., Cobitz, Alexander R.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Nephrology 2016
Materias:
Clinical Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4814173/
https://ncbi.nlm.nih.gov/pubmed/26494831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2014111139
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares